York Capital Management Global Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

York Capital Management Global Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-100,000	Closed	-$3.55M	–	85
2018 Q1	$3.55M	Buy	100,000 +8,608	+9%	+$337K	0.08%	68
2017 Q4	$3.98M	Buy	+91,392	New	+$4.27M	0.1%	63
2017 Q2	–	Sell	-109,945	Closed	-$5.04M	–	83
2017 Q1	$5.04M	Buy	+109,945	New	+$5.47M	0.12%	60

Other funds holding SYNH

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

York Capital Management Global Advisors's SYNH Position: Q2 2018 in Review

York Capital Management Global Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2018, closing a stake of 100,000 shares — an estimated $3.55M sold.

York Capital Management Global Advisors first reported a position in SYNH in Q1 2017 and held it in 3 quarters. The position peaked at $5.04M in Q1 2017. 213 funds tracked by Wall St. Rank hold SYNH as of Q2 2018.

York Capital Management Global Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2018 after selling out during the quarter.
York Capital Management Global Advisors sold 100,000 Syneos Health, Inc. Class A Common Stock shares in Q2 2018, an estimated $3.55M.
York Capital Management Global Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2017 and held it in 3 quarters.
York Capital Management Global Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $5.04M in Q1 2017.
213 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2018.

Based on York Capital Management Global Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.